Last update 04 Jan 2026

Coding EpCAM/CD3 Bispecific Antibody mRNA

Overview

Basic Info

Drug Type
mRNA encoding bispecific antibody, Bispecific T-cell Engager (BiTE)
Synonyms
ABO2202
Target
CD3 x EpCAM
Action
modulators, inhibitors
Mechanism
CD3 modulators(T cell surface glycoprotein CD3 modulators), EpCAM inhibitors(Epithelial cell adhesion molecule inhibitors)
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Secondary malignant neoplasm of peritoneumStomach Cancer
Inactive Indication-
Originator Organization
Suzhou Abogen Biosciences Co., Ltd.Suzhou Abogen Biosciences Co., Ltd.
Active Organization
Suzhou Abogen Biosciences Co., Ltd.Suzhou Abogen Biosciences Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseClinical
First Approval Date-
Regulation-

Related

1
Clinical Trials associated with Coding EpCAM/CD3 Bispecific Antibody mRNA
ChiCTR2400088554
/ Not yet recruitingNot ApplicableIIT
A Clinical Study to Evaluate the Safety and Initial Efficacy of Coding EpCAM/CD3 Bispecific Antibody mRNA in Advanced Gastric Cancer With Peritoneal Metastasis Subjects
100 Clinical Results associated with Coding EpCAM/CD3 Bispecific Antibody mRNA
Login to view more data
100 Translational Medicine associated with Coding EpCAM/CD3 Bispecific Antibody mRNA
Login to view more data
100 Patents (Medical) associated with Coding EpCAM/CD3 Bispecific Antibody mRNA
Login to view more data
100 Deals associated with Coding EpCAM/CD3 Bispecific Antibody mRNA
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Secondary malignant neoplasm of peritoneumClinical
China
Suzhou Abogen Biosciences Co., Ltd.Suzhou Abogen Biosciences Co., Ltd.
16 May 2024
Stomach CancerClinical
China
Suzhou Abogen Biosciences Co., Ltd.Suzhou Abogen Biosciences Co., Ltd.
16 May 2024
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free